Yuichi Takatsuka

2.3k citations

91 papers · 1.7k indexed · h-index 22

Co-authors: Shinzaburo Noguchi Tomohiko Aihara José Bines Pierre Dubé Katarína Petráková Aman U. Buzdar Luigi Cataliotti Célia Tosello Oliveira
Topics: Breast Cancer Treatment Studies (43 papers)Cancer Treatment and Pharmacology (23 papers)HER2/EGFR in Cancer Research (18 papers)
Cited by: Cancer Research Oncology Pharmacology
Journals: Journal of Clinical Oncology Cancer Journal of Power Sources
Partner nations: Japan United States Switzerland

In The Last Decade

Yuichi Takatsuka

86 papers receiving 1.6k citations

Peers

Countries citing papers authored by Yuichi Takatsuka

Since Specialization

Citations

This map shows the geographic impact of Yuichi Takatsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Takatsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Takatsuka more than expected).

Fields of papers citing papers by Yuichi Takatsuka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Takatsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Takatsuka. The network helps show where Yuichi Takatsuka may publish in the future.

Co-authorship network of co-authors of Yuichi Takatsuka

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Takatsuka. A scholar is included among the top collaborators of Yuichi Takatsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Takatsuka. Yuichi Takatsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel 2018 ·Clinical Breast Cancer ·Yoshimasa Miyagawa,Kazuhiro Araki,(unknown),(unknown),Yukie Fujimoto,Tomoko Higuchi,Arisa Nishimukai,(unknown),Michiko Imamura,Yuichi Takatsuka,Yasuo Miyoshi	44
2	Spontaneous regression of primary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) colliding with invasive ductal carcinoma of the breast: a case report. 2014 ·PubMed Central ·Ikuo Matsuda,Takahiro Watanabe,(unknown),Yuichi Takatsuka,Yasuo Miyoshi,Seiichi Hirota	2
3	Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers 2014 ·Breast Cancer ·Tomoko Yagi,Natsuko Inoue,Ayako Yanai,Keiko Murase,Michiko Imamura,Yoshimasa Miyagawa,(unknown),Arisa Nishimukai,Yuichi Takatsuka,Seiichi Hirota,Kouhei Akazawa,Yasuo Miyoshi	10
4	High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer 2014 ·Clinical Breast Cancer ·Arisa Nishimukai,Tomoko Yagi,Ayako Yanai,Yoshimasa Miyagawa,(unknown),Keiko Murase,Michiko Imamura,Yuichi Takatsuka,Isao Sakita,Takuya Hatada,Yasuo Miyoshi	35
5	C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis 2013 ·Breast Cancer ·Tomohiro Miyake,Takashi Ito,Ayako Yanai,Natsuko Inoue,Yoshimasa Miyagawa,Keiko Murase,Michiko Imamura,Shigetoshi Ichii,Yuichi Takatsuka,Tomoyuki Nishizaki,Seiichi Hirota,Masahisa Ohtsuka,Hirofumi Yamamoto,Shinzaburo Noguchi,Yasuo Miyoshi	6
6	A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane 2012 ·International Journal of Clinical Oncology ·Yasuhiro Suzuki,Toshiaki Saeki,Kenjiro Aogi,Masakazu Toi,Hirofumi Fujii,Kenichi Inoue,Toru Watanabe,Yasuhiro Fujiwara,Yoshinori Ito,Yuichi Takatsuka,Hiroji Iwata,Hitoshi Arioka,Yutaka Tokuda	4
7	Randomized phase II study of three doses of oral TAS‐108 in postmenopausal patients with metastatic breast cancer 2012 ·Cancer Science ·Hideo Inaji,Hiroji Iwata,Takahiro Nakayama,Naohito Yamamoto,Yasuyuki Sato,Yutaka Tokuda,Kenjiro Aogi,Shigehira Saji,Kenichi Watanabe,Tsuyoshi Saito,Masayuki Yoshida,Nobuaki Sato,Toshiaki Saeki,Yuichi Takatsuka,Masaru Kuranami,Hiroko Yamashita,Atsushi Kikuchi,Toshio Tabei,Tadashi Ikeda,Shinzaburo Noguchi	6
8	Outcomes of Japanese breast cancer patients treated with pre‐operative and post‐operative anastrozole or tamoxifen 2011 ·Cancer Science ·Yasuhiro Fujiwara,Yuichi Takatsuka,Shigeru Imoto,Hideo Inaji,Tadashi Ikeda,Futoshi Akiyama,(unknown),(unknown),Hiroji Iwata,Shoshu Mitsuyama,Shinzaburo Noguchi	3
9	A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese 2011 ·Human Molecular Genetics ·Kazuma Kiyotani,Taisei Mushiroda,Tatsuhiko Tsunoda,Takashi Morizono,Naoya Hosono,Michiaki Kubo,Yusuke Tanigawara,Chiyo K. Imamura,David A. Flockhart,(unknown),Koichi Hirata,Yuichi Takatsuka,M. Okazaki,Shozo Ohsumi,Takashi Yamakawa,Mitsunori Sasa,Yusuke Nakamura,Hitoshi Zembutsu	34
10	Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology 2010 ·International Journal of Clinical Oncology ·Takuro Shimbo,Tsuguya Fukui,Chikashi Ishioka,Kohji Okamoto,Takahiro Okamoto,Shingo Kameoka,Atsushi Satō,Masakazu Toi,Kunihiko Matsui,Toshihiko Mayumi,Shigetoyo Saji,Masaru Miyazaki,Yuichi Takatsuka,Koichi Hirata	8
11	Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)] 2010 ·Oncology ·Tetsuya Taguchi,Norikazu Masuda,Takahiro Nakayama,Kazuyoshi Motomura,Fumine Tsukamoto,Kenzo Shimazu,Takashi Nomura,Takashi Morimoto,Hiroshi Yamamoto,(unknown),(unknown),(unknown),Hideo Inaji,Yuichi Takatsuka,Shinzaburo Noguchi	9
12	Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer 2010 ·Gastric Cancer ·Shigeyuki Tamura,Hirofumi Miki,Kaoru Okada,Atsushi Takeno,(unknown),(unknown),Rei Suzuki,Shin Nakahira,Chiyomi Egawa,Ken Nakata,Shu Okamura,(unknown),Yuichi Takatsuka	12
13	Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes 2008 ·Cancer Chemotherapy and Pharmacology ·Takanori Ishida,Takayoshi Kiba,Motohiro Takeda,(unknown),Satoshi Teramukai,Ryota Ishiwata,Norikazu Masuda,Yuichi Takatsuka,Shinzaburo Noguchi,Chikashi Ishioka,Masanori Fukushima,Noriaki Ohuchi	28
14	Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients 2006 ·Breast Cancer ·Toshiaki Saeki,Shigemitsu Takashima,Masami Ogita,Toshio Tabei,Isamu Adachi,Kazuo Tamura,Yuichi Takatsuka,(unknown)	2
15	Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma 2005 ·Breast Cancer ·Hiroji Iwata,Seigo Nakamura,Masakazu Toi,Eisei Shin,Norikazu Masuda,Shinji Ohno,Yuichi Takatsuka,K Hisamatsu,Kosuke Yamazaki,M. Kusama,Hiroshi Kaise,Yasuyuki Sato,Katsumasa Kuroi,Futoshi Akiyama,Hitoshi Tsuda,Masafumi Kurosumi	17
16	Phase II Study of Concurrent Administration of Doxorubicin and Docetaxel as First-Line Chemotherapy for Metastatic Breast Cancer 2003 ·Oncology ·Tomohiko Aihara,Yuichi Takatsuka,Kuniaki Itoh,Yasutsuna Sasaki,Noriyuki Katsumata,Toru Watanabe,Shinzaburo Noguchi,N Horikoshi,Toshio Tabei,Hiroshi Sonoo,Shunkichi Hiraki,Hideo Inaji	10
17	Optimal management of the axilla in patients with Breast Cancer 2000 ·Breast Cancer ·Eisei Shin,Yukiko Minami,Yuichi Takatsuka,(unknown),A Kurata,Toshimasa Tsujinaka	1
18	Adjuvant chemotherapy for early Breast Cancer 2000 ·Breast Cancer ·Yuichi Takatsuka,Takeshi Tominaga	4
19	Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases 2000 ·Cancer ·Takeshi Tono,Yasunori Hasuike,Hiroki Ohzato,Yuichi Takatsuka,Nobuteru Kikkawa	63
20	The Significance of Second Hepatectomy for Recurrent Metastases from Colorectal Primaries. 1995 ·The Japanese Journal of Gastroenterological Surgery ·Takeshi Tono,Nobuteru Kikkawa,(unknown),Hideyuki Mishima,Yasuhiro Tamaki,Eisei Shin,Kenji Kobayashi,Yuichi Takatsuka	2

About Yuichi Takatsuka

Yuichi Takatsuka is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 91 papers that have together received 1.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (43 papers), Cancer Treatment and Pharmacology (23 papers) and HER2/EGFR in Cancer Research (18 papers). The work is most often cited by research in Cancer Research (707 citations), Oncology (940 citations) and Pharmacology (186 citations). Yuichi Takatsuka has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Shinzaburo Noguchi, Tomohiko Aihara, José Bines, Pierre Dubé, Katarína Petráková, Aman U. Buzdar, Luigi Cataliotti, Célia Tosello Oliveira, Hideo Morino and Nobuteru Kikkawa. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Power Sources.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact